IMMUNEWALK
DEAD

Serial Number

98252485

Owner

ImmuneWalk Therapeutics Inc.

Attorney

Monica Riva Talley

Filing Date

Nov 2, 2023

Add to watchlist:

No watchlists yet
View on USPTO

IMMUNEWALK Trademark

Serial Number: 98252485

IMMUNEWALK is a trademark filed by ImmuneWalk Therapeutics Inc. on November 2, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ImmuneWalk Therapeutics Inc. (3 trademarks)

Suite 1509
Pearl River, NY 10965

Entity Type: 03

Trademark Details

Filing Date

November 2, 2023

Registration Date

Not Registered

Published for Opposition

October 1, 2024

Goods & Services

Pharmaceutical preparations for the prevention and treatment of immune system diseases and disorders, central nervous system disorders, chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, Inflammatory kidney diseases, inflammatory bowel disease, rheumatoid arthritis, inflammatory pulmonary disease, atherosclerosis, infectious diseasesĀ and disorders, chronic inflammatory disease, and cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for immune system diseases and disorders, central nervous system disorders, chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, inflammatory kidney diseases, inflammatory bowel disease, rheumatoid arthritis, inflammatory pulmonary disease, atherosclerosis, infectious diseases and disorders, chronic inflammatory disease, and cancer; Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for regulating immune response; Nutritional and dietary supplements for immune system support

Research and development in the pharmaceutical, biopharmaceutical, and biotechnology fields; research and development of pharmaceutical preparations and medicines; medical and scientific research services; pharmaceutical and biopharmaceutical product evaluation; consulting in the field of pharmaceutical, biopharmaceutical, and biotechnology research; testing of pharmaceuticals; scientific laboratory services and medical research laboratory services.

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 29, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 29, 2025 ABN6
ASSIGNED TO EXAMINER
Oct 23, 2025 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
May 3, 2025 EX1G
SOU EXTENSION 1 FILED
May 2, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
May 2, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 26, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 1, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 1, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 11, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 26, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 26, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 26, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 26, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 26, 2024 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 13, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 13, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 13, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 13, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 20, 2023 NWOS
NEW APPLICATION ENTERED
Nov 6, 2023 NWAP